Adhesion of multiple myeloma peripheral blood B cells to bone marrow fibroblasts: A requirement for CD44 and α4β7

Cancer Research

Volumn 57, Issue 5, 1997, Pages 930-936

  Masellis Smith, Anna ^a   Belch, Andrew R ^a   Mant, M J ^a   Pilarski, Linda M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; INTEGRIN;

ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL ADHESION; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MULTIPLE MYELOMA; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD19; ANTIGENS, CD44; B-LYMPHOCYTES; BONE MARROW CELLS; CELL ADHESION; CELL ADHESION MOLECULES; CHO CELLS; CRICETINAE; ENDOTHELIUM, VASCULAR; FIBROBLASTS; FIBRONECTINS; HUMANS; HYALURONIC ACID; IMMUNOGLOBULINS; INTEGRIN ALPHA4; INTEGRIN BETA CHAINS; INTEGRINS; MOLECULAR SEQUENCE DATA; MUCOPROTEINS; MULTIPLE MYELOMA; PEPTIDES; PROTEIN BINDING; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0031018167     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Witzig, T. E., Dhodapkar, M. V., Kyle, R. A., and Greipp, P. R. Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma. Cancer (Phila.), 72; 108-113, 1993.
2. Dreyfus, F., Meile, J., Quarre, C., and Pillier, C. Contamination of peripheral blood by monoclonal B cells following treatment of muluple myeloma by high dose chemotherapy. Br, J. Hematol., 85: 411-412, 1993.
3. + peripheral blood cells expressing CD38, CD56, and monotypic immunoglobulin light chain. Blood, 85: 436-447, 1995.
4. Pilarski, L. M., Mant, M. J., and Belch, A. R. Circulating monoclonal, multi-drug resistant B cells may comprise the malignant stem cell population in multiple myeloma. In: F. Dammaco and B. Barlogie (eds.), Challenges in Modern Medicine, Vol. 4, p. 31. Ares Sereno Symphosia Publications, 1994.
5. + cells in the blood of patients with multiple myeloma express CD19 and IgH mRNA and have patient-specific IgH VDJ gene rearrangements. Blood, in press, 1997.
6. Pilarski, L. M., and Belch, A. R. Circulating monoclonal B cells expressing Pglycoprotein may be a reservoir of multidrug resistant disease in multiple myeloma. Blood, 83: 724-736, 1994.
7. Pilarski, L, M., and Belch, A. R. Intrinsic expression of the multidrug transporter, P-glycoprotein 170, in multiple myeloma: implications for treatment, Leuk. & Lymphoma, 17: 367-374, 1995.
8. Jensen G. S, Belch, A. R., Kherani, F., Mant, M. J., Ruether, B. A., and Pilarski, L. M. Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients, Scand. J. Immunol., 36: 843-853, 1992.
9. Pilarski, L. M., and Jensen, G. S. Expression of CD45 isoforms (leukocyte common antigen) and adhesion molecules during normal and abnormal B lymphocyte development. Adv. Mol. Cell Immunol., IB: 75-117, 1993.
10. Jensen, G. S., Belch, A. R., Mant, M. J., Ruether, B. A., Yacyshyn, B. R., and Pilarski, L. M. Expression of multiple β-1 integrins on circulating monoclonal B cells in patients with multiple myeloma. Am. J. Hematol., 43; 29-36, 1992.
11. Masellis-Smith, A., Belch, A. R., Mant, M. J., Turley, E. A., and Pilarski, L. M. Hyaluronan (HA)-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate usage of RHAMM and CD44. Blood, 87: 1891-1899, 1996.
12. Caligaris-Cappio, F., Bergui, L., Gregorett, M. G., Gaidano, G., Gaboli, G., Schena, M., Zallone, A. Z., and Marchisio, P. C. Role of bone marrow stromal cells in the growth of human multiple myeloma. Blood, 77: 2688-2693, 1991.
13. Kawano, M. M., Mihara, K., Huang, N., Tsujimoio, T., and Kuramoto, A. Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis. Blood, 85: 487-494, 1995.
14. Uchiyama, H., Barut, B. A., Chauhan, D., Cannistra, S. A., and Anderson, K. C. Characterization of adhesion molecules on human myeloma cell lines. Blood, 80: 2306-2314, 1992.
15. Kim, I., Uchiyama, H., Chauhan, D., and Anderson, K. C. Cell surface expression and functional significance of adhesion molecules on human myeloma-derived cell lines. Br. J. Haematol., 87: 483-493, 1994.
16. Lockhorst, H. M., Lamme, T., de Smet, M., Klein, S., de Weger, R. A., van Oers, R., and C. Bloem, A. Primary tumor cells in myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures. Blood, 84: 2269-2277, 1994.
17. Zola, H., Macardle, P. J., Bradford, T., Weedon, H., Yaui, H., and Kurosawa, Y. Preparation and characterization of a chimeric CD 19 monoclonal antibody. Immunol. Cell Biol., 69: 411-422, 1991.
18. Salomon, D. FITC Labelling. In: I E. Coligan. A. M. Kruisbeek, D, H. Margulies. E. M. Shevach, and W. Strober (eds.), Current Protocols in Immunology, Vol. 1, Suppl. 1. New York: John Wiley & Sons. Inc., 1991.
19. + cells in multiple myeloma are B cells. Blood, 86: 58a, 1995.
20. Berlin, C., Berg, E. L., Briskin, M. J., Andrew, D. P., Kilshaw, P. J., Holzmann, B., Weissman, I. L., Hamann, A., and Butcher, E. C. α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell, 74: 185-195, 1993.
21. Shygan, A. M., Bertagnolli, M., Kenney, C. J., and Briskin, M. J. Human mucosal addressin cell adhesion molecule-1 (MAdCAM-1) demonstrates structural and functional similarities to the α4β7-integrin binding domains of murine MAdCAM-1, but extreme divergence of mucin-like sequences. J. Immunol., 156: 2851-2857, 1996.
22. Wayner, E. A., and Kovach, N. L. Activation-dependent recognition by hematopoietic cells of the LDV sequence in the V region of fibronectin. J. Cell Biol., 116: 489-497, 1992.
23. Bosman, P. T. Integrins: cell adhesives and modulators of cell function. Histochem. J., 25: 469-477, 1993.
24. Ager, A., and Humphries, M. J. Integrin α4β1 : its structure. ligand-binding specificity and role in lymphocyte-endothelial cell interactions. In: N. Hogg (ed.), Integrins and ICAM-1 in Immune Responses. Chemical Immunoogy Series, Vol. 50, p. 55. Farmington, CT: S. Karger, 1991.
25. Hemler, M. E., Elices, M. J., Parken C., and Takada, Y. Structure of the integrin VLA-4 and its cell-cell and cell-matrix adhesion functions. Immunol, Rev., 114: 45-65, 1990.
26. Pilurski, L. M., and Jensen, G. S. Monoclonal circulating B cells in multiple myeloma: a continuously differentiating, possibly invasive population as defined by expression of CD45 isoforms and adhesion molecules, Hematol, Oncol. Clin. North Am., 6: 297-322, 1992.
27. Oen, K., Danell, G., Stewart, S., Wilkins, J., and Tazumi, K. Adhesion of peripheral blood lymphocytes of children with arthritis to human umbilical vein endothelial cells. Clin. Exp. Immunol., 95: 415-423. 1994.
28. Erle, D. J., Briskin, M. J., Butcher, E. C., Garcia-Pardo, A., Lazarovits, A. I., and Tidswell, M. Expression and function of the MAdCAM-1 receptor, integrin αβ7, on human leukocytes. J. Immunol., 153: 517-528, 1994.
29. Postigo, A. A., Sanchez-Maieos, P., Lazarovits, A. I., Sanchez-Madrid, F., and De Landuzuri, M. O. α407 integrin mediates B cell binding to fibronectin and VCAM-1: expression and function of α4 on human B lymphocytes. J. Immunol., 151: 2471-2483, 1993,
30. Altevogts P., Hubbe, M., Ruppert, M., Lohr, J., von Hoegen, P., Sammar, M., Andrew, D. P., McEvoy, L., Humphries, M. J., and Butcher, E. C. The α4 integrin chain is a ligand for α4β7 and α4βl. J. Exp. Med., 182: 345-355, 1995.
31. Chan, B. M. C., Elices, M. J., Murphy, E., and Hemler, M. E. Adhesion to vascular cell adhesion molecule 1 and fibronectin: comparison of α4βl (VLA-4) and α4β7 on the human B cell line JY. J. Biol. Chem., 267; 8366-8370. 1992,
32. Wayner, E. A., Gurcia-Pardo, A., Humphries, M. J., McDonald, J. A., and Carter, W. G. Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J. Cell Biol., 109; 1321-1330, 1989.
33. Humphries, M. J., Komoriya, A., Akiyama, S. K., Olden, K., and Yamada, K. M. Identification of two distinct regions of the type III connecting segment of human plasma fibronectin that promote cell type-specific adhesion. J. Biol. Chem., 262; 6886-6892, 1987.
34. Mould, A. P., and Humphries, M. J. Identification of a novel recognition sequence for the integrin α4β1 in the COOH-terminal heparin binding domain of fibronectin. EMBO J., 10: 4089-4095, 1991.
35. Ruoslahti, E., and Pierschbacher, M. D. New perspectives in cell adhesion: RGD and integrins. Science (Washington DC), 238: 491-497, 1987.
36. Mould, P. A., Askari, J. A., Craig, S. E., Garratt, A. N., Clements, J., and Humphries, M. J. Integrin α4β7-mediated melanoma cell adhesion and migration on vascular cell adhesion molecule-1 (VCAM-1) and the alternatively spliced IIICS region of fibronectin. J. Biol. Chem., 269: 27224-27230, 1994.
37. Tang, J., Scott, G., and Ryan, D. H. Subpopulations of bone marrow fibroblasts support VLA-4 mediated migration of B-cell precursors. Blood, 82: 3415-3423, 1993.
38. Miyake, K., Medina, K. L., Huyashi, S., Ono, S., Hamaoka, T., and Kincade, P. W. Monoclonal antibodies to Pgp-l/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J. Exp. Med., 171: 477-488, 1990.
39. Droll, A., Dougherty, S. T., Chiu, R. K., Dirks, J. F., McBride, W. H., Cooper, D. L., and Dougherty, G. J. Adhesive interactions between alternatively spliced CD44 isoforms. J. Biol. Chem., 270: 11567-11573, 1995.
40. Stupack, D. G., Shen, C., and Wilkins, J. A. Control of lymphocyte integrin function: evidence for multiple contributing factors. Cell. Immunol., 155: 237-245, 1994.
41. Postigo, A. A., Pulido, R., Campanero, M. R., Acevedo, A., Garcia-Pardo, A., Corbi, A. L., Sanchez-Madrid, F., and Landazuri, M. O. Differential expression of VLA-4 integrin by resident and peripheral blood B lymphocytes: acquisition of functionally active α4β1 fibronectin receptors upon B cell activation. Eur. J. Immunol., 21: 2437-2445, 1991.
42. Verfaillie, C. M., Benis, A., Lida, J., McGlave, P. B., and McCarthy, J. B, Adhesion of committed human hematopoietic progenitors to synthetic peptides from the C-terminal heparin-binding domain of fibronectin: cooperation between the integrin and the CD44 adhesion receptor. Blood. 84: 1802-1811, 1994.
43. Clark, B. R., Gallagher, J. T., and Dexter, T. M. Cell adhesion in the stromal regulation of haemopoiesis. Bailliere's Clin. Haematol., 5: 619-652, 1992.
44. Gordon, M. Y., Riley, G. P., and Clarke, D. Heparan sulfate is necessary for adhesive interactions between human early hemopoietic progenitor cells and the extracellular matrix of the marrow microenvironment. Leukemia (Baltimore). 2: 804-809, 1988.
45. Luikart, S. D., Maniglia, C. A., Furcht, L. T., McCarthy, J. B., and Oegema, T. R., Jr. A heparan sulfate-ccmtaining fraction of bone marrow stroma induces maturation of HL-60 cells in vitro. Cancer Res., 50: 3781-3785, 1990.
46. Morimoto, K., Robin, E., Le Bousse-Kerdiles, M. C., Li. Y., Clay, D., Jasmin, C., and Smadja-Joffe, F. CD44 mediates hynluronon binding by human myeloid KG1A and KG1 cells. Blood, 83: 657-662, 1994,
47. Bartolazzi, A., Peach, R., Arufo, A., and Stamenkovic, I. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J. Exp. Med., 180: 53-66, 1994.
48. Sy, M., GUO, Y., and Stamenkovic, I. Inhibition of tumor growth in viva with a soluble CD44-immunoglobulin fusion protein. J. Exp. Med., 176: 623-627, 1992.
49. Vonderheide, R. H., Tedder, T. F., Springer, T. A., and Staunton, D. E. Residues within a conserved amino acid motif of domain 1 and 4 of VCAM-1 are required for binding VLA-1. J. Cell Biol., 125: 215-222, 1994.
50. Kilger, G., Needham, L. A., Nielsen, P. J., Clements, J., Vestweber, D., and Holzmann, B. Differential regulation of α4 integrin-depcndem binding to domains 1 and 4 of vascular cell adhesion molecule-1. J. Biol. Chem., 270: 5979-5984, 1995.